Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Nor-Ursodeoxycholic Acid - Shilpa Medicare

Next Previous
Search
Drug Profile

Nor-Ursodeoxycholic Acid - Shilpa Medicare

Alternative Names: NorUDCA - Shilpa Medicare; SMLNUD-07

Latest Information Update: 09 May 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Shilpa Medicare
  • Class Anti-inflammatories; Cholic acids; Gallstone therapies; Hepatoprotectants; Small molecules
  • Mechanism of Action Cholesterol inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Non-alcoholic fatty liver disease

Most Recent Events

  • 12 Mar 2025 Phase-III clinical trials in Non-alcoholic fatty liver disease in India (PO)
  • 12 Mar 2025 Shilpa Medicare plans to launch Nor-Ursodeoxycholic Acid for treatment of non-alcoholic fatty liver disease in India
  • 12 Mar 2025 Efficacy and adverse events data from a phase III Non-alcoholic fatty liver disease released by Shilpa Medicare

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top